Using the expression levels of these three key genes, we predicted the prognosis of CRC patients and found that high expression of COQ2 and MPC1 was associated with better prognosis, while high expression of ADAMTS13 corresponded to a negative prognosis (Figures 2C–E). This evidence concerns the gene MPC1 and colorectal carcinoma.